We’re in the DRWF Winter 2026 Newsletter

DRWF helped fund the early development of Noctura 400 back in 2005. We we able to market the product from 2014, when we obtained our CE mark

Noctura 400 is supplied to patients by ASPH NHS Trust!

We’re really happy that Noctura 400 is now available from one NHS Trust, and it’s great to be featur...

PolyPhotonix were at Stand E02, Diabetes Professional Care event, London last week, showing off the ...

Noctura 400 is featured in a Daily Mail report explaining the cost saving it could bring if adopted ...

During Diabetes Week 2022 on TopDoctorsUK, the Chief Investigator of a recent successful Noctura 400...

CEO Richard Kirk talks about the development and successes of Noctura 400. With an in depth understa...

An Italian Noctura 400 patient talks about his diabetic life experience, the very real possibility o...

It seems like you’re running a default WordPress website. Here are a few useful links to get you sta...